Literature DB >> 8490506

Chronic liver disease due to hepatitis C.

S Levi1, C Foster, H J Hodgson, K N Ward, A So, J A Garson, J Waxman, D Swirsky.   

Abstract

The low concentration of hepatitis C virus in the blood of infected patients has made it difficult to detect. Infected patients can now be identified by using more sensitive immunoassays and amplification of viral RNA by the polymerase chain reaction. Nevertheless, the virus remains difficult to eliminate. We present the case of a woman with a history of autoimmune haemolytic anaemia, thrombocytopenia, and common variable immunodeficiency who developed chronic hepatitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8490506      PMCID: PMC1677020          DOI: 10.1136/bmj.306.6884.1054

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  5 in total

1.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

2.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 3.  Alzheimer's disease and metal-containing glia.

Authors:  J K Young
Journal:  Med Hypotheses       Date:  1992-05       Impact factor: 1.538

4.  Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus.

Authors:  M Ragozzino; L J Melton; C P Chu; P J Palumbo
Journal:  J Chronic Dis       Date:  1982

5.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis.

Authors:  G Kuo; Q L Choo; H J Alter; G L Gitnick; A G Redeker; R H Purcell; T Miyamura; J L Dienstag; M J Alter; C E Stevens
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

  5 in total
  3 in total

Review 1.  Human Immunoglobulins for intravenous use and hepatitis C viral transmission.

Authors:  H B Slade
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

2.  Hepatitis C from immunoglobin infusions.

Authors:  P S Lehner; A D Webster
Journal:  BMJ       Date:  1993-06-05

3.  Rapidly progressive hepatitis C in a patient with common variable immunodeficiency.

Authors:  R Sumazaki; T Matsubara; T Aoki; Y Nagai; M Shibasaki; H Takita
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.